Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Karyopharm Therapeut 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 USA

P: 617-658-0600

Description:

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 751,681
Shares Outstanding, K 75,093
Annual Sales, $ 108,090 K
Annual Net Income, $ -196,270 K
Last Quarter Sales, $ 23,260 K
Last Quarter Net Income, $ -57,410 K
60-Month Beta 0.28
% of Insider Shareholders 10.24%
% of Institutional Shareholders 80.08%
Float, K 67,403
% Float 89.76%

Growth:

1-Year Return -45.43%
3-Year Return -46.41%
5-Year Return 33.11%
5-Year Revenue Growth 43,136.00%
5-Year Earnings Growth 18.07%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/03/21
Earnings Per Share ttm -2.72
EPS Growth vs. Prev Qtr -30.51%
EPS Growth vs. Prev Year 1.28%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

KPTI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -5.19
Price/Earnings to Growth N/A
Return-on-Equity % -357.73%
Return-on-Assets % -61.51%
Profit Margin % -181.58
Net Margin % N/A
Debt/Equity 2.33
Price/Sales 7.16
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.53
Interest Coverage -6.22
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar